CTS (CTS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
28 Jul, 2026Executive summary
Revenue grew 7% year-over-year to $145 million in Q2 2026, with diversified end markets up 15% and representing 59% of total sales, offsetting modest declines in transportation.
Achieved record profitability: gross margin at 41.5%, adjusted EBITDA margin at 25.4%, and adjusted diluted EPS at $0.74, including $0.07 from unusual items.
Net income for Q2 2026 was $19.2 million (13.2% of sales), up from $18.5 million in Q2 2025.
CEO transition announced with Pratik Trivedi succeeding Kieran O'Sullivan effective July 6, 2026.
Book-to-bill ratio was 1.1 overall, with diversified markets at 1.17, indicating strong demand.
Financial highlights
Adjusted gross margin reached a record 41.5%, up 270 basis points year-over-year.
Adjusted EBITDA margin improved by 240 basis points to 25.4% year-over-year.
Adjusted diluted EPS was $0.74, up from $0.57 in Q2 2025, with $0.07 from FX and customer reimbursement.
Operating cash flow was $33.4 million; free cash flow was $28.8 million.
Cash and cash equivalents at quarter-end were $108 million; borrowings at $55 million.
Outlook and guidance
Full-year 2026 sales guidance raised to $565–$585 million; adjusted diluted EPS expected at $2.55–$2.70.
Diversified end markets expected to maintain growth; transportation volumes forecasted flat to slightly down.
No material impact anticipated from recent tariff announcements; ongoing monitoring of geopolitical and cost environments.
Latest events from CTS
- Strong growth and innovation in sensing and motion solutions drive 10% annual revenue targets.CTS
Investor presentation28 Jul 2026 - Q4 revenue up 9% with strong diversified growth; 2026 outlook remains positive.CTS
Q4 20259 Jul 2026 - Q3 2024 saw higher margins and EPS, with diversified growth offsetting transportation declines.CTS
Q3 20248 Jul 2026 - Medical, industrial, and defense growth outpace automotive, with strong margins and disciplined M&A.CTS
16th Annual East Coast IDEAS Conference11 Jun 2026 - Q1 2026 delivered 11% sales growth, margin expansion, and robust earnings improvement.CTS
Q1 202630 Apr 2026 - Diversified growth and innovation support strong financial outlook and long-term expansion.CTS
Investor presentation29 Apr 2026 - 2025 saw diversified growth, strong cash flow, and continued focus on governance and ESG.CTS
Proxy filing2 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the 2026 meeting.CTS
Proxy filing2 Apr 2026 - Q2 2024 sales fell 10% year-over-year, but net income and defense diversification improved.CTS
Q2 20242 Feb 2026